Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L-type voltage-operated calcium channels (L-type Ca²⁺ channels) are a subtype of voltage-gated calcium channels (VGCCs) found in the membranes of excitable cells such as cardiac, skeletal, and smooth muscle cells, as well as neurons. They play a critical role in coupling membrane depolarization to cellular responses by mediating the influx of Ca²⁺ ions upon activation by strong depolarizations. They are composed of α1, α2δ, β, and γ subunits, with the α1 subunit forming the ion-conducting pore. Different α1 subunit isoforms (Cav1.1, Cav1.2, Cav1.3, Cav1.4) exist with distinct tissue distributions and physiological roles. They are major drug targets for treating cardiovascular diseases like hypertension and angina.
Reduction of calcium entry into cells, decreasing contractility or excitability
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L-type Voltage-Operated Calcium Channel (L-type Ca²⁺ channels).